🇺🇸 FDA
Pipeline program

MVA-NP+M1

FLU010

Phase 2 mab completed

Quick answer

MVA-NP+M1 for Influenza is a Phase 2 program (mab) at Barinthus Biotherapeutics plc. with 2 ClinicalTrials.gov record(s).

Program details

Company
Barinthus Biotherapeutics plc.
Indication
Influenza
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials